Cambridge, Massachusetts, United States The leading representative office of defined Corporate Investor is situated in the Cambridge. The venture was found in North America in United States.
The current fund was established by Peter Parker, Susie Truong Harborth.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Sentien Biotechnologies, Vaxess Technologies. The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the BioInnovation, startups are often financed by National Science Foundation, National Institutes of Health. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, SR One, Roche Venture Fund. In the next rounds fund is usually obtained by National Science Foundation, National Institutes of Health, Bill & Melinda Gates Foundation.
The high activity for fund was in 2017. Speaking about the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
Funds with similar focus
| Fund Name | Location |
| BPC Investments | - |
| Bridge Boys | Boston, Massachusetts, United States |
| Cactus Communications | India, Maharashtra, Mumbai |
| CHUGIN LEASE | Japan, Okayama, Okayama Prefecture |
| D Capital Partners | New York, New York, United States |
| Fouse KK | - |
| GWN Ltd | - |
| Hancom | Kyonggi-do, Seongnam, South Korea |
| Hangzhou Nuanliu Investment Management | China, Hangzhou, Zhejiang |
| Heron Capital | Carmel, Indiana, United States |
| Implistic Capital | Las Vegas, Nevada, United States |
| JTB Publishing | Japan, Tokyo |
| Lanua Asia fund | - |
| Market One Capital | Luxembourg, Luxembourg |
| New Fortress Energy | New York, New York, United States |
| Novo Nordisk Foundation | Capital Region of Denmark, Denmark, Hovedstaden |
| PIMCO | California, Newport Beach, United States |
| UVM 2 Venture Investments | Central, Central Region, Singapore |
| W&W brandpool | Baden-Wurttemberg, Germany, Stuttgart |
| zipdragon ventures | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pandion Therapeutics | $80M | 01 Apr 2020 | Cambridge, Massachusetts, United States | ||
| $8M | 27 Jun 2019 | Cambridge, Massachusetts, United States | |||
Pandion Therapeutics | $58M | 17 Jan 2018 | Cambridge, Massachusetts, United States | ||
Sentien Biotechnologies | $12M | 04 Apr 2017 | Massachusetts, United States | ||
Pegase Medical | $2M | 31 May 2007 | Quebec City, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Pandion Therapeutics | $80M | 01 Apr 2020 | Cambridge, Massachusetts, United States | ||
| $8M | 27 Jun 2019 | Cambridge, Massachusetts, United States | |||
Pandion Therapeutics | $58M | 17 Jan 2018 | Cambridge, Massachusetts, United States | ||
Sentien Biotechnologies | $12M | 04 Apr 2017 | Massachusetts, United States | ||
Pegase Medical | $2M | 31 May 2007 | Quebec City, Quebec, Canada |
